Analyst Upgrades
- Citigroup upgraded Deutsche Bank (NYSE: DB) to Hold from Sell citing reduced legacy risks and strength in the fixed income franchise.
- Janney Montgomery upgraded Fuel Systems (NASDAQ: FSYS) to Buy from Neutral based on valuation, the OEM market in Europe for alternative transportation is growing faster than expected, and the $30M equity raise was smaller than expected.
- Freeport McMoRan (NYSE: FCX) was upgraded to Outperform from Market Perform by FBR Capital. The firm believes that the company will benefit from copper supply issues over the long term, and it thinks the stock has reached an attractive entry point.
- Black & Decker (NYSE: BDK) was upgraded to Neutral from Underperform at Credit Suisse.
- American Tower (NYSE: AMT) was raised to Overweight from Neutral at JPMorgan.
- EMC Corp. (NYSE: EMC) was upgraded at Barclays to Overweight from Equal Weight.
Analyst Downgrades
- Janney Montgomery downgraded Wright Express (NYSE: WXS) to Neutral from Buy citing Treasury regulatory reform that proposes all commercial enterprises that own nonbank subsidiaries convert to a bank-holding company status or forfeit FDIC deposit insurance access. Wright Express owns an industrial loan corporation and the firm views the proposal as a negative.
- Oppenheimer downgraded Boeing (NYSE: BA) to Underperform from Perform citing 787 delay concerns and favors aftermarket suppliers where growth is predicated on a bottom in air traffic vs. new aircraft deliveries.
- JMP Securities downgraded shares of Monogram Biosciences (NASDAQ: MGRM) to Market Perform from Outperform following the acquisition announcement by LabCorp (NYSE: LH).
- Alliance Data Systems (NYSE: ADS) was downgraded to Neutral from Overweight at JPMorgan.
- Jefferies downgraded Harmonic (NASDAQ: HLIT) to Hold from Buy.
Analyst Initiations
- FBR Capital initiated Riverbed Technology (NASDAQ: RVBD) with a Market Perform rating and $22 target. The firm believes Riverbed's near-term growth may be limited given increased competition and the difficult spending environment.
- Deutsche Bank initiated OSI Pharmaceuticals (NASDAQ: OSIP) with a Hold rating and $33 target citing near-term concerns over reimbursement changes and lack of catalysts.
- Auriga initiated Adtran (NASDAQ: ADTN) with a Buy rating and $26 target and believes the new TA5000 product line appears poised to deliver on its long-held promise of rejuvenating the top and bottom lines. The firm notes that the potential fallout from the pending Verizon (NYSE: VZ) deal with Frontier for the sale of 4.8mn rural telephone lines, has the potential to disrupt a vital Adtran customer.
- DigitalGlobe (NYSE: DGI) was initiated with a Buy rating and $21 target at BofA/Merrill.
- Johnson Controls (NYSE: JCI) was initiated with a Buy rating at Merriman.










